Kiniksa Pharmaceuticals (KNSA)
NASDAQ:KNSA
US Market
Holding KNSA?
Track your performance easily

Kiniksa Pharmaceuticals (KNSA) Income Statement

428 Followers

Kiniksa Pharmaceuticals Income Statement

Last quarter (Q3 2024), Kiniksa Pharmaceuticals's total revenue was $112.21M, an increase of 57.00% from the same quarter last year. In Q3, Kiniksa Pharmaceuticals's net income was $-12.69M. See Kiniksa Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 371.29M$ 270.26M$ 220.18M$ 38.54M--
Cost of Revenue
$ 71.52M$ 33.41M$ 22.89M$ 9.10M--
Gross Profit
$ 359.77M$ 236.85M$ 197.28M$ 29.44M--
Operating Expense
$ 321.07M$ 262.05M$ 187.51M$ 185.25M$ 157.36M$ 169.96M
Operating Income
$ -20.62M$ -25.20M$ 9.77M$ -156.64M$ -157.36M$ -169.96M
Net Non Operating Interest Income Expense
--$ -1.25M$ 97.00K$ 1.13M$ 6.05M
Other Income Expense
$ 7.41M$ 8.54M$ 1.25M$ -97.00K--
Pretax Income
$ -10.95M$ -16.65M$ 11.03M$ -156.54M$ -156.23M$ -163.91M
Tax Provision
$ -5.73M$ -30.74M$ -172.34M$ 1.39M$ 5.15M$ -2.05M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -5.22M$ 14.08M$ 183.36M$ -157.92M$ -161.38M$ -161.87M
Basic EPS
$ -0.07$ 0.20$ 2.64$ -2.30$ -2.61$ -2.99
Diluted EPS
$ -0.07$ 0.20$ 2.60$ -2.30$ -2.61$ -2.99
Basic Average Shares
$ 283.30M$ 70.06M$ 69.38M$ 68.58M$ 61.84M$ 54.05M
Diluted Average Shares
$ 289.04M$ 71.92M$ 70.42M$ 68.58M-$ 54.05M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 91.75M$ 295.45M$ 210.41M$ 194.34M$ 157.36M$ 169.96M
Net Income From Continuing And Discontinued Operation
$ -5.22M$ 14.08M$ 183.36M$ -157.92M$ -161.38M$ -161.87M
Normalized Income
$ -4.85M-----
Interest Expense
------
EBIT
$ -13.40M$ -25.20M$ 9.77M$ -156.64M$ -157.36M$ -163.91M
EBITDA
$ -12.26M$ -22.86M$ 12.18M$ -154.28M$ -154.96M$ -165.35M
Currency in USD

Kiniksa Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis